1YH3 |
1.91 |
Crystal structure of human CD38 extracellular domain |
1ZVM |
2.2 |
Crystal structure of human CD38: cyclic-ADP-ribosyl synthetase/NAD+ glycohydrolase |
2EF1 |
2.4 |
Crystal structure of the extracellular domain of human CD38 |
2HCT |
1.95 |
Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine NAAPD synthesis and hydrolysis activities |
2I65 |
1.9 |
Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis |
2I66 |
1.7 |
Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis |
2I67 |
1.71 |
Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis |
2O3Q |
1.98 |
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 |
2O3R |
1.75 |
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 |
2O3S |
1.5 |
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 |
2O3T |
1.68 |
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 |
2O3U |
2.11 |
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 |
2PGJ |
1.71 |
Catalysis associated conformational changes revealed by human cd38 complexed with a non-hydrolyzable substrate analog |
2PGL |
1.76 |
Catalysis associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog |
3DZF |
2.01 |
Crystal structure of human CD38 extracellular domain complexed with a covalent intermediate, ara-F-ribose-5'-phosphate |
3DZG |
1.65 |
Crystal structure of human CD38 extracellular domain, ara-F-ribose-5'-phosphate/nicotinamide complex |
3DZH |
1.6 |
Crystal structure of human CD38 extracellular domain, GTP complex |
3DZI |
1.73 |
Crystal structure of human CD38 extracellular domain, ribose-5'-phosphate intermediate/GTP complex |
3DZJ |
1.9 |
Crystal structure of human CD38 extracellular domain E226Q mutant, NMN complex |
3DZK |
1.81 |
Crystal structure of human CD38 extracellular domain, NMN complex |
3F6Y |
1.45 |
Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium |
3I9M |
1.75 |
Crystal structure of human CD38 complexed with an analog ara-2'F-ADPR |
3I9N |
2.01 |
Crystal structure of human CD38 complexed with an analog ribo-2'F-ADP ribose |
3OFS |
2.2 |
Dynamic conformations of the CD38-mediated NAD cyclization captured using multi-copy crystallography |
3RAJ |
3.044 |
Crystal structure of human CD38 in complex with the Fab fragment of antibody HB7 |
3ROK |
1.65 |
Crystal structure of human CD38 in complex with compound CZ-27 |
3ROM |
2.04 |
Crystal structure of human CD38 in complex with compound CZ-48 |
3ROP |
1.94 |
Crystal structure of human CD38 in complex with compound CZ-50b |
3ROQ |
2.1 |
Crystal structure of human CD38 in complex with compound CZ-46 |
3U4H |
1.878 |
CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose template |
3U4I |
2.118 |
CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose template |
4CMH |
1.53 |
Crystal structure of CD38 with a novel CD38-targeting antibody SAR650984 |
4F45 |
2.1 |
Crystal structure of human CD38 E226Q mutant in complex with NAADP |
4F46 |
1.69 |
Crystal structure of wild type human CD38 in complex with NAADP and ADPRP |
4OGW |
2.05 |
Structure of a human CD38 mutant complexed with NMN |
4TMF |
2.05 |
Crystal structure of human CD38 in complex with hydrolysed compound JMS713 |
4XJS |
2.8 |
Human CD38 complexed with inhibitor 1 [6-fluoro-2-methyl-4-[(2,3,6-trichlorobenzyl)amino]quinoline-8-carboxamide] |
4XJT |
2.6 |
Human CD38 complexed with inhibitor 2 [4-[(2,6-dimethylbenzyl)amino]-2-methylquinoline-8-carboxamide] |
5F1K |
2.3 |
human CD38 in complex with nanobody MU1053 |
5F1O |
2.2 |
human CD38 in complex with nanobody MU551 |
5F21 |
1.9 |
human CD38 in complex with nanobody MU375 |
6EDR |
2.4 |
Crystal Structure of Human CD38 in Complex with 4'-Thioribose NAD+ |
6VUA |
1.5 |
X-ray structure of human CD38 catalytic domain with 2'-Cl-araNAD+ |
7DHA |
2.55 |
crystal structure of CD38 in complex with daratumumab |
7DUO |
2.81 |
Crystal structure of daratumumab fab and CD38 complex |
7VKE |
1.9 |
Crystal structure of human CD38 ECD in complex with UniDab(TM) F11A |
8D0M |
2.04 |
Human CD38 ectodomain bound to a 78c-ADPR adduct |
8IL3 |
3.86 |
Cryo-EM structure of CD38 in complex with FTL004 |